Attached files
| file | filename |
|---|---|
| 10-Q - QUARTERLY REPORT - TG THERAPEUTICS, INC. | v222330_10q.htm |
| EX-31.1 - EXHIBIT 31.1 - TG THERAPEUTICS, INC. | v222330_ex31-1.htm |
EXHIBIT 32.1
CERTIFICATIONS
OF
PRINCIPAL EXECUTIVE OFFICER
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Manhattan Pharmaceuticals, Inc. does hereby certify that, to the best of his knowledge:
(a) the Quarterly Report on Form 10-Q of Manhattan Pharmaceuticals, Inc. for the quarter ended March 31, 2011 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(b) information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Manhattan Pharmaceuticals, Inc.
|
Dated: May 16, 2011
|
/s/ Michael G. McGuinness
|
|
|
Michael G. McGuinness
|
||
|
Principal Executive and Financial Officer
|
||